TXMD - セラピュ―ティクスMD (TherapeuticsMD Inc.)

TXMDのニュース

   TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences  2020/09/10 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to participate in two virtual investor conferences in September
   TherapeuticsMD Announces Patent Updates for ANNOVERA®  2020/09/09 20:05:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD increases patent protection on ANNOVERA
   TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020  2020/07/29 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET on such date to discuss the Company’s financial results and provide a business update. Conference Call & Audio Webcast
   TherapeuticsMD and Nurx Expand Access to ANNOVERA®  2020/07/15 10:50:00 Business Wire
BOCA RATON, Fla. & SAN FRANCISCO--(BUSINESS WIRE)--TXMD expands access to Annovera through arrangement with Nurx, the largest online practice for women's health
   TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer  2020/06/01 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from his position as the Company’s Chief Financial Officer, also effective June 1, 2020. Mr. Cartwright will remain with the Company as an advisor for a transitional period. Mr. D’Arecca joins TherapeuticsM
   TherapeuticsMD and Nurx Expand Access to ANNOVERA®  2020/07/15 10:50:00 Business Wire
BOCA RATON, Fla. & SAN FRANCISCO--(BUSINESS WIRE)--TXMD expands access to Annovera through arrangement with Nurx, the largest online practice for women's health
   TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer  2020/06/01 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from his position as the Company’s Chief Financial Officer, also effective June 1, 2020. Mr. Cartwright will remain with the Company as an advisor for a transitional period. Mr. D’Arecca joins TherapeuticsM
   TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference  2020/05/08 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD's CEO to present at BofA Securities 2020 Health Care Conference to be held virtually on May 13 at 9:40 a.m. ET
   TherapeuticsMD Announces First Quarter 2020 Financial Results  2020/05/06 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD releases financial and business results for Q1 2020; Q1 revenue exceeded Wall Street consensus; conference call scheduled for today at 8:30 a.m.
   TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®  2020/04/29 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD obtains patent protection for ANNOVERA into 2039
   TherapeuticsMD and Nurx Expand Access to ANNOVERA®  2020/07/15 10:50:00 Business Wire
BOCA RATON, Fla. & SAN FRANCISCO--(BUSINESS WIRE)--TXMD expands access to Annovera through arrangement with Nurx, the largest online practice for women's health
   TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer  2020/06/01 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from his position as the Company’s Chief Financial Officer, also effective June 1, 2020. Mr. Cartwright will remain with the Company as an advisor for a transitional period. Mr. D’Arecca joins TherapeuticsM
   TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference  2020/05/08 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD's CEO to present at BofA Securities 2020 Health Care Conference to be held virtually on May 13 at 9:40 a.m. ET
   TherapeuticsMD Announces First Quarter 2020 Financial Results  2020/05/06 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD releases financial and business results for Q1 2020; Q1 revenue exceeded Wall Street consensus; conference call scheduled for today at 8:30 a.m.
   TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®  2020/04/29 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD obtains patent protection for ANNOVERA into 2039

calendar